UPTRAVI

Product NDC: 66215-718
11-digit product format: 662150718
Labeler code: 66215
Product ID: 66215-718_cf17e19e-ac3d-4787-88e8-f4cc7f4fcc74
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Selexipag
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Actelion Pharmaceuticals US, Inc.
Application: NDA214275
Marketing category: NDA
Marketing start: 2021-07-29
Substance: SELEXIPAG
Active strength: 1800 ug/10mL
Pharmacologic classes: Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N214275-001	UPTRAVI	SELEXIPAG	1.8MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2021-07-29

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27
N214275-001	7205302*PED	2027-04-30		Pediatric extension
N214275-001	9173881	2029-08-12	U-1798		2021-08-27
N214275-001	9173881*PED	2030-02-12		Pediatric extension
N214275-001	9284280	2030-06-25	U-1831		2021-08-27
N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27
N214275-001	9284280*PED	2030-12-25		Pediatric extension
N214275-001	8791122*PED	2031-02-01		Pediatric extension

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`782e0a99824c…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N214275-001	UPTRAVI	1.8MG/VIAL	POWDER / INTRAVENOUS	RLD, RS	2021-07-29	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 148 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	7205302*PED	2027-04-30		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	9173881*PED	2030-02-12		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	9284280*PED	2030-12-25		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214275-001	8791122*PED	2031-02-01		Pediatric extension		`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	7205302*PED	2027-04-30		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	9173881*PED	2030-02-12		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	9284280*PED	2030-12-25		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214275-001	8791122*PED	2031-02-01		Pediatric extension		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214275-001	7205302	2026-10-31	U-1797	Drug substance, Drug product	2021-08-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214275-001	9173881	2029-08-12	U-1798		2021-08-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214275-001	9284280	2030-06-25	U-1831		2021-08-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214275-001	8791122	2030-08-01		Drug substance, Drug product	2021-08-27	`2680178bc6a6…`

Additional Listing Data#

Finished product: Yes
Brand name base: UPTRAVI
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
SELEXIPAG	1800 ug/10mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5EXC0E384L	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 2 · 24 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1729007	Internal RxNorm lookup
1729013	Internal RxNorm lookup
1729027	Internal RxNorm lookup
1729029	Internal RxNorm lookup
1729031	Internal RxNorm lookup
1729033	Internal RxNorm lookup
1729045	Internal RxNorm lookup
1729047	Internal RxNorm lookup
1729051	Internal RxNorm lookup
1729053	Internal RxNorm lookup
1729055	Internal RxNorm lookup
1729057	Internal RxNorm lookup
1729059	Internal RxNorm lookup
1729061	Internal RxNorm lookup
1729063	Internal RxNorm lookup
1729065	Internal RxNorm lookup
1729075	Internal RxNorm lookup
1729076	Internal RxNorm lookup
2565271	Internal RxNorm lookup
2565275	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a7a23b87-f892-4e2c-8e2e-ebf841220f90	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
3940235d-2369-40fe-94e3-68f58494a1a8	Product name	3	20250627
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
66215-718-01	UPTRAVI	10 mL in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, FOR SOLUTION	10		25
66215-718-01	UPTRAVI	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1		25

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66215-718-01	EA - Each	66215-718	0bfd68d0-135d-4437-a80b-19529add251b	1	2021-09-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66215-718	UPTRAVI (SELEXIPAG) TABLET, COATED UPTRAVI TITRATION PACK (SELEXIPAG) KIT UPTRAVI (SELEXIPAG) INJECTION, POWDER, FOR SOLUTION [ACTELION PHARMACEUTICALS US, INC.]	24	Current NDC, Legacy NDC, 2 package rows	20240709_a7a23b87-f892-4e2c-8e2e-ebf841220f90.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UPTRAVI	SELEXIPAG	Actelion Pharmaceuticals US, Inc.	a7a23b87-f892-4e2c-8e2e-ebf841220f90	2026-05-28	Warnings, Adverse reactions	Exact identifier application applno (NDA): 214275 application number: NDA214275 ndc (product): 66215-718

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5EXC0E384L	SELEXIPAG	475086-01-2	SELEXIPAG

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1729076	{140 (selexipag 0.2 MG Oral Tablet [Uptravi]) / 60 (selexipag 0.8 MG Oral Tablet [Uptravi]) } Pack [Uptravi Titration Pack]	BPCK	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729075	{140 (selexipag 0.2 MG Oral Tablet) / 60 (selexipag 0.8 MG Oral Tablet) } Pack	GPCK	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729007	selexipag 1000 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729027	selexipag 1200 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729031	selexipag 1400 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729045	selexipag 1600 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
2565271	selexipag 1800 MCG Injection	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729075	selexipag 200 MCG (140), selexipag 800 MCG (60) Oral Tablet Titration Pack	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729051	selexipag 200 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729055	selexipag 400 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729059	selexipag 600 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729063	selexipag 800 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729013	Uptravi 1000 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729029	Uptravi 1200 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729033	Uptravi 1400 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729047	Uptravi 1600 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
2565275	Uptravi 1800 MCG Injection	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729053	Uptravi 200 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729057	Uptravi 400 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729061	Uptravi 600 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729065	Uptravi 800 MCG Oral Tablet	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729076	Uptravi Titration Pack	PSN	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729053	selexipag 0.2 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729057	selexipag 0.4 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729061	selexipag 0.6 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729065	selexipag 0.8 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729013	selexipag 1 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729029	selexipag 1.2 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729033	selexipag 1.4 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729047	selexipag 1.6 MG Oral Tablet [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
2565275	selexipag 1.8 MG Injection [Uptravi]	SBD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729051	selexipag 0.2 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729055	selexipag 0.4 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729059	selexipag 0.6 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729063	selexipag 0.8 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729007	selexipag 1 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729027	selexipag 1.2 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729031	selexipag 1.4 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729045	selexipag 1.6 MG Oral Tablet	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
2565271	selexipag 1.8 MG Injection	SCD	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729076	{140 (selexipag 200 MCG Oral Tablet [Uptravi]) / 60 (selexipag 800 MCG Oral Tablet [Uptravi]) } Pack [Uptravi Titration Pack]	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729075	{140 (selexipag 200 MCG Oral Tablet) / 60 (selexipag 800 MCG Oral Tablet) } Pack	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729007	selexipag 1000 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729027	selexipag 1200 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729031	selexipag 1400 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729045	selexipag 1600 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729051	selexipag 200 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729055	selexipag 400 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729059	selexipag 600 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729063	selexipag 800 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729053	Uptravi 0.2 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729057	Uptravi 0.4 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729061	Uptravi 0.6 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729065	Uptravi 0.8 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729013	Uptravi 1 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729029	Uptravi 1.2 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729033	Uptravi 1.4 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729047	Uptravi 1.6 MG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
2565275	Uptravi 1.8 MG Injection	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729013	Uptravi 1000 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729029	Uptravi 1200 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
2565275	Uptravi 1800 MCG Injection	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729053	Uptravi 200 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729057	Uptravi 400 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729061	Uptravi 600 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729065	Uptravi 800 MCG Oral Tablet	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26
1729076	Uptravi Titration Pack	SY	a7a23b87-f892-4e2c-8e2e-ebf841220f90	26

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
66215-718-01	66215071801	1 VIAL, SINGLE-DOSE in 1 CARTON (66215-718-01) / 10 mL in 1 VIAL, SINGLE-DOSE	2021-07-29	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
UPTRAVI	Actelion Pharmaceuticals US, Inc. \| Butterworth Laboratories Ltd \| Wickham Micro Limited \| Almac Sciences Limited \| Almac Pharma Services Limited \| EUROFINS AMATSIGROUP SAS \| Eurofins Amatsi Analytics \| SGS Institut Fresenius GmbH \| Excella GmbH & Co. KG \| Konapharma AG \| Confarma France	2026-05-28	HUMAN PRESCRIPTION DRUG LABEL	26